Gary C. Starling

3.0k citations

59 papers · 2.6k indexed · h-index 28

Impact in

Immunology top 1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
Hematology top 2%
- Multiple Myeloma Research and Treatments

Papers in

Immunology 40
- Immune Cell Function and Interaction 21
- Immunotherapy and Immune Responses 15
- T-cell and B-cell Immunology 13
- Immune Response and Inflammation 6
Immunology and Allergy 9
- Cell Adhesion Molecules Research 9

Co-authors: Peter A. Kiener Derek N.J. Hart Alejandro Aruffo Patricia M. Davis W. Conrad Liles Alexander D. McLellan Michael A. Bowen Barry D. Hock
Journals: The Journal of Immunology (5 papers)European Journal of Immunology (5 papers)Blood (4 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)The Journal of Experimental Medicine (2 papers)
Partner nations: United States New Zealand Germany

In The Last Decade

Gary C. Starling

59 papers receiving 2.5k citations

Peers

Countries citing papers authored by Gary C. Starling

Since Specialization

Citations

This map shows the geographic impact of Gary C. Starling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary C. Starling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary C. Starling more than expected).

Fields of papers citing papers by Gary C. Starling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary C. Starling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary C. Starling. The network helps show where Gary C. Starling may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gary C. Starling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary C. Starling Line = papers co-authored together Gary C. Starling links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells Journal of Immunology Research ·Shiming Ye, Melvin Fox, Nicole A. Belmar, Mien Sho, Debra T. Chao, Kumari Megha, И.С. Богатырёв, 藤城吉徳, 表永平, Gary C. Starling, Patricia Culp	2017	12
2	BTNL8, a butyrophilin-like molecule that costimulates the primary immune response Molecular Immunology ·Andrei I. Chapoval, Glennda Smithson, 泰博上平, Mehdi Mesri, Ferenc Boldog, David P. Andrew, Nikolai V. Khramtsov, Elena A Feshchenko, Gary C. Starling, Peter Mézeš	2013	27
3	Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb Journal of Cancer Research and Clinical Oncology ·Debra T. Chao, Jesi Quan Bautista, Maria Cláudia Hahn Ferrucio, Mien Sho, Donghee Choi, Hoa-Thi Nguyen, Shiming Ye, Eric D. Hsi, Lisa Durkin, Johnny Yin, Yongke Zhang, Han Kim, Gary C. Starling, Patricia Culp	2012	28
4	Antagonism of PDGF-D by Human Antibody CR002 Prevents Renal Scarring in Experimental Glomerulonephritis Journal of the American Society of Nephrology ·Tammo Ostendorf, Song Rong, Peter Boor, Lyle H. Kendall, Uta Kunter, Paul O'Dowd, Claudia R.C. van Roeyen, Frank Eitner, Hiroshi Kawachi, Gary C. Starling, Enrique Álvarez, Glennda Smithson, JuCombining Diaeresisrgen Floege	2006	56
5	Serum Levels of CD137 Ligand and CD178 are Prognostic Factors for Progression of Myelodysplastic Syndrome Leukemia & lymphoma ·Helmut R. Salih, V. Nuessler, Claudio Denzlinger, Gary C. Starling, Peter A. Kiener, Helga Schmetzer	2003	12
6	Differentiation of promyelocytic leukaemia: alterations in Fas (CD95/Apo‐1) and Fas Ligand (CD178) expression British Journal of Haematology ·Helmut R. Salih, Gary C. Starling, Germán A. Ramírez, R. Pelka‐Fleischer, Torsten Haferlach, Wolfgang Hiddemann, Peter A. Kiener, V. Nuessler	2002	10
7	Soluble CD137 (4-1BB) Ligand Is Released Following Leukocyte Activation and Is Found in Sera of Patients with Hematological Malignancies The Journal of Immunology ·Helmut R. Salih, Helga Schmetzer, Christine Burke, Gary C. Starling, Robert R. Dunn, R. Pelka‐Fleischer, V. Nuessler, Peter A. Kiener	2001	52
8	Retinoic Acid and Vitamin E Modulate Expression and Release of CD178 in Carcinoma Cells: Consequences for Induction of Apoptosis in CD95-Sensitive Cells Experimental Cell Research ·Helmut R. Salih, Gary C. Starling, Markus Knauff, P. S. Tiwan, Patricia M. Davis, William J. Pitts, Alejandro Aruffo, Peter A. Kiener	2001	9
9	Constitutive Expression of Functional 4-1BB (CD137) Ligand on Carcinoma Cells The Journal of Immunology ·Helmut R. Salih, Rashad Mohammed Hassan Al-Hakim, M. Guay, Gary C. Starling, Deryk Loo, Francis Lee, Alejandro Aruffo, Pamela A. Trail, Peter A. Kiener	2000	70
10	Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development Cell Death and Differentiation ·Alexander D. McLellan, S. Vaghela, Thilo Mengling, Gary C. Starling, Peter A. Kiener, Rebecca Gold, Netanel Anor, M. Leverkus, Eckhart Kämpgen	2000	36
11	Identification of Amino Acid Residues Important for Ligand Binding to Fas The Journal of Experimental Medicine ·Gary C. Starling, Jürgen Bajorath, John Emswiler, Jeffrey A. Ledbetter, Alejandro Aruffo, Peter A. Kiener	1997	64
12	Identification of the Tumor Antigen 90K Domains Recognized by Monoclonal Antibodies SP2 and L3 and Preparation and Characterization of Novel Anti-90K Monoclonal Antibodies Biochemical and Biophysical Research Communications ·Nicola Tinari, Maurizia DʼEgidio, Stefano Iacobelli, Michael A. Bowen, Gary C. Starling, Carrie L. Seachord, Richard P. Darveau, Alejandro Aruffo	1997	18
13	Characterization of mouse ALCAM (CD166): the CD6‐binding domain is conserved in different homologs and mediates cross‐species binding European Journal of Immunology ·Michael A. Bowen, Jürgen Bajorath, Maurizia DʼEgidio, Gena S. Whitney, Gianluca A. Arianna, Jörg Kobarg, Gary C. Starling, Anthony W. Siadak, Alejandro Aruffo	1997	74
14	Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and Macrophages The Journal of Experimental Medicine ·Peter A. Kiener, Patricia M. Davis, Gary C. Starling, Christopher Mehlin, Seymour J. Klebanoff, Jeffrey A. Ledbetter, W. Conrad Liles	1997	217
15	The Membrane-proximal Scavenger Receptor Cysteine-rich Domain of CD6 Contains the Activated Leukocyte Cell Adhesion Molecule Binding Site Journal of Biological Chemistry ·Gena S. Whitney, Gary C. Starling, Michael A. Bowen, Brett Modrell, Anthony W. Siadak, Alejandro Aruffo	1995	78
16	New Molecules on Dendritic Cells and Their Interactions with T Lymphocytes Advances in experimental medicine and biology ·Derek N.J. Hart, Gary C. Starling, William Egner, Barry D. Hock, Alexander D. McLellan, Judith L. McKenzie, Lisa A. Williams, David L. Simmons	1995	1
17	Isolation of human blood dendritic cells by discontinuous Nycodenz gradient centrifugation Journal of Immunological Methods ·Alexander D. McLellan, Gary C. Starling, Derek N.J. Hart	1995	53
18	A novel HLA-A∗8001 Allele identified in an African-American population Human Immunology ·Gary C. Starling, Samantha Monico, Khoirotun Nikmah, Susan McKinney, John A. Hansen, S. Yoon Choo	1994	11
19	Selection of an unrelated donor for marrow transplantation facilitated by the molecular characterization of a novel HLA-A allele Human Immunology ·S. Yoon Choo, Gary C. Starling, Claudio Anasetti, John A. Hansen	1993	18
20	Molecular cloning of a novel member of the immunoglobulin gene superfamily homologous to the polymeric immunoglobulin receptor European Journal of Immunology ·David G. Jackson, Derek N.J. Hart, Gary C. Starling, Lucian Criste	1992	48

About Gary C. Starling

Gary C. Starling is a scholar working on Immunology, Immunology and Allergy, Hematology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 59 papers that have together received 2.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (21 papers), Immunotherapy and Immune Responses (15 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), T-cell and B-cell Immunology (13 papers), Cell Adhesion Molecules Research (9 papers), Lymphoma Diagnosis and Treatment (7 papers), Immune Response and Inflammation (6 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Immunology (1.6k citations), Hematology (417 citations), Immunology and Allergy (180 citations), Oncology (658 citations) and Molecular Biology (894 citations). Gary C. Starling has collaborated with scholars based in United States, New Zealand and Germany. Frequent co-authors include Peter A. Kiener, Derek N.J. Hart, Alejandro Aruffo, Patricia M. Davis, W. Conrad Liles, Alexander D. McLellan, Michael A. Bowen, Barry D. Hock, Jeffrey A. Ledbetter and Jürgen Bajorath. Their work appears in journals such as The Journal of Immunology, European Journal of Immunology, Blood, Bioorganic & Medicinal Chemistry Letters and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact